Tu Youyou's team: New breakthrough in research on 'artemisinin resistance'
After years of hard work, Tu Youyou and her team have made new breakthroughs in the areas of "anti-malarial mechanism research", "causes of drug resistance" and "adjustment of treatment methods", and recently proposed practical treatment solutions to deal with the problem of "artemisinin resistance", and made new progress in "artemisinin treatment for lupus erythematosus and other indications" and "the export of traditional Chinese medicine scientific research papers", which have been highly recognized by the World Health Organization and authoritative experts at home and abroad.
Professor Cox, editor-in-chief of the Oxford Textbook of Medicine, said he was pleased with the upcoming inclusion of traditional Chinese medicine treatises in the textbook. He said: "The chapter on Chinese medicine is both important and in-depth. It is all the result of the outstanding efforts of Chinese scientists." Pedro Alonso and other leading experts believe that Tu Youyou's team has built a bridge between traditional medicine and modern medicine, allowing Chinese medicine to be not only widely used in China, but also recognized in more and more countries for its effective treatment. We hope Chinese scientists will continue to make more noise in the international arena of artemisinin research.
Chinese Medicine Innovation Development
2026-08-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China's Ibuprofen Export Performance, First Half of 2026
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
The relationship between Digital Transformation and Work- Life Balance in the Egyptian Pharmaceutical Industry
-
What Does the Future Hold for the Anti-Obesity Drug Market in 2024?
-
Hengrui entered the top 20 for the first time. How big is the gap between Chinese and American pharmaceutical companies?
-
The State Food and Drug Administration accepted the marketing application of Ditze Pharma suvortinib
-
Jimin's innovative polycystic kidney disease innovative drug was approved by the FDA for clinical trials
-
Another giant may be broken up
-
NASH is on the verge of a new drug, and the 40-year black hole is finally shining a light
-
Novo Nordisk Shanghai and ShanghaiPharmaceutical Holdings sign a contract to make another breakthrough incooperation
Recommend Reading
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Air Liquide to Acquire Korea’s DIG Airgas for €2.85 Billion
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
Invista Reshuffles Global Nylon 66 Map: Shutting US and UK Plants, Betting Big on China—What Exactly Are They Aiming For?
-
Profits Are Rising, but So Are the Risks—China’s Coatings Industry Is Living Through Its Most Awkward Year
-
Potassium Carbonate: Properties, Uses, and Applications
-
MTBE Market Trend Weakly Consolidates
-
MTBE Market Trends Show Signs of Slowing Down
-
Styrene-butadiene Rubber Market Prices Slightly Rise
-
This week, the coke market in China showed a narrow and weak trend (10.17-10.24)